» Authors » Takahiro Kuragano

Takahiro Kuragano

Explore the profile of Takahiro Kuragano including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 83
Citations 566
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kosugi T, Hasegawa T, Imaizumi T, Nishiwaki H, Honda H, Ito Y, et al.
Clin Exp Nephrol . 2025 Feb; PMID: 39932639
Background: The optimal hemoglobin (Hb) range in patients undergoing hemodialysis remains controversial. We aimed to investigate the association between Hb levels and mortality in patients undergoing hemodialysis and explore the...
2.
Nishiwaki H, Imaizumi T, Hasegawa T, Kosugi T, Maruyama Y, Tsuruya K, et al.
Am J Nephrol . 2025 Feb; :1-11. PMID: 39894014
Introduction: We evaluated the association between iron-related biomarkers - key indicators of iron metabolism and inflammation, and crucial in the management of anemia in patients undergoing hemodialysis - and all-cause...
3.
Kosugi T, Hasegawa T, Imaizumi T, Nishiwaki H, Honda H, Ito Y, et al.
J Ren Nutr . 2025 Jan; PMID: 39864472
Objectives: Anemia is a common complication associated with adverse outcomes in older patients undergoing hemodialysis (HD). They also tend to experience malnutrition, which can affect the course of anemia. We...
4.
Imaizumi T, Hasegawa T, Kosugi T, Nishiwaki H, Abe M, Hanafusa N, et al.
Sci Rep . 2025 Jan; 15(1):2689. PMID: 39838061
Preservation of residual kidney function (RKF) is important in patients undergoing peritoneal dialysis (PD). We aimed to examine the association between anemia management and residual urine output using data from...
5.
Takata C, Kuma A, Suwabe A, Iwasaki T, Kuragano T
CEN Case Rep . 2024 Oct; PMID: 39397226
Acute interstitial nephritis (AIN) is known to cause acute kidney injury and is characterized by immunocyte infiltration and interstitial fibrosis. Primary etiologies include drugs, infections, and autoimmune disorders. Herein, we...
6.
7.
Kuragano T
Int J Mol Sci . 2024 Jul; 25(13). PMID: 39000429
Traditionally, the treatment of anemia associated with chronic kidney disease (CKD) involves prescribing erythropoiesis-stimulating agents (ESAs) or iron preparations. The effectiveness and safety of ESAs and iron have been established....
8.
Mimura Y, Kojima K, Fujikawa A, Okada S, Fujimori A, Kuma A, et al.
BMC Nephrol . 2024 Jun; 25(1):196. PMID: 38872134
Background: TAFRO syndrome is a rare disorder that causes thrombocytopenia, generalized oedema, fever, organ enlargement, and renal impairment. Few reports have suggested an association with vaccines, and few cases have...
9.
Imaizumi T, Hasegawa T, Kosugi T, Nishiwaki H, Honda H, Tsuruya K, et al.
Perit Dial Int . 2024 Jun; :8968608241244995. PMID: 38826118
Background: Clinical data supporting the target haemoglobin range in patients undergoing peritoneal dialysis (PD) are scarce. This study investigated the association between haemoglobin levels and all-cause mortality in Japanese patients...
10.
Nakanishi T, Kuragano T
Clin Kidney J . 2024 Mar; 17(3):sfae051. PMID: 38516524
Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) have emerged as a novel therapeutic class for treating anemia in patients with chronic kidney disease. Small molecule analogs of α-ketoglutarate (AKG), an essential...